Ken Pastor is a founding general partner at CTI Life Sciences Fund with over 30 years in finance and investment banking. He created GlyPharma and VectivBio, and serves on the board of CQDM.
What Ken can write
Career
- CTI LSF · Associé général fondateur
- Merrill Lynch
- CTI Capital
- CTI Life Sciences Fund · Managing PartnerNow
Companies founded
Investments named in public bios
Focus
Education
Also at CTI Life Sciences Fund
Partners like Ken
At firms with a similar stage, sector and check size.
Alert me when CTI Life Sciences Fund is active
One email when Ken's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Ken Pastor?
Ken Pastor is a founding general partner at CTI Life Sciences Fund with over 30 years in finance and investment banking. He created GlyPharma and VectivBio, and serves on the board of CQDM.
How much does Ken Pastor invest?
CTI Life Sciences Fund has not reported a check size. It invests at pre-seed, seed, series a.
How do I pitch Ken Pastor?
A warm intro from a founder CTI Life Sciences Fund backed works best.
What did Ken Pastor do before CTI Life Sciences Fund?
Associé général fondateur at CTI LSF; Merrill Lynch; CTI Capital.
Last updated 2026-10-15. Is this you? Ask for a correction.